Welcome to TaMADOR
Two NIDDK programs, one focused on Type 1 Diabetes and one focused on Obesity, funded research groups with the goal of developing and disseminating targeted mass spectrometry assays for the diagnosis and monitoring of Type 1 Diabetes and Obesity. While the funding sources are separate, we felt there were obvious synergies in these efforts and formed TaMADOR with the goal of leveraging each other's capabilities and strengths.
NIH Funding Announcements
Type 1 Diabetes Assays
University of Washington
Quantifying Proteins in Plasma to Democratize Personalized Medicine for Patients with Type 1 Diabetes
PIs: Andrew Hoofnagle, Michael MacCoss
PNNL & University at Buffalo
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications
PIs: Jun Qu, Wei-Jun Qian
Obesity Assays
Cedars-Sinai Medical Center
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity
PI: Jennifer Van Eyk
Pacific Northwest National Laboratory
Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of Obesity
PI: Wei-Jun Qian
Participating Institutions
News & Announcements
View all →-
US HUPO 2026 Evening Workshop: Targeting Diabetes and Obesity
February 22, 2026The TaMADOR consortium hosted a successful evening workshop at the 2026 US HUPO Conference in St. Louis, Missouri. Workshop: Targeting Diabetes and Obesity: MS-based Assays that Inform Clinical Re...
-
Register Now for the 2026 TaMADOR Spring Symposium
February 11, 2026Targeted Mass Spectrometry Assays for Diabetes and Obesity Research (TaMADOR) The 2026 TaMADOR Spring Symposium will be held on May 14th from 8:30 AM to 4:10 PM at UW Medicine, South Lake Union (B...
-
2025 TaMADOR Meeting at the NIH
March 4, 2025The TaMADOR consortium held a symposium at the National Institutes of Health on March 4, 2025: Biomarkers and Mass Spectrometry–Based Assays in Type 1 Diabetes Clinical Research. The precise and a...
-
New Publications Page
April 25, 2024We have launched a new page listing the publications from the four grants that have supported TaMADOR: U01 DK137097 (University of Washington) U01 DK137113 (Pacific Northwest National Laborat...
-
Register Now for the 2024 TaMADOR Symposium
March 28, 2024Targeted Mass Spectrometry Assays for Diabetes and Obesity Research (TaMADOR) The 2024 TaMADOR Symposium will be held on May 6th from 8am to 4pm at UW Medicine, South Lake Union (Brotman Auditoriu...